CORE SCIENTIFIC INC

Core Scientific CFO James Nygaard receives a 120k‑share RSU grant, balancing insider sales with long‑term stakes – what this means for investors and the company’s AI‑focused growth.

Core Scientific insider Todd DuChene’s May 18 sell‑off reveals a deliberate, rule‑based trimming of 200k+ shares, hinting at a cautious view on its AI‑driven future.

Core Scientific’s new RSU grant for Chief Accounting Officer Ray Jorge L. shows strong executive confidence amid insider selling, signaling continued growth potential and aligning leadership with shareholder interests.

Core Scientific insider sale reveals liquidity strategy amid bullish market – explore the impact on future growth and investor sentiment.

Insider selling at Core Scientific may signal short‑term pressure, but AI‑focused growth and strong fundamentals suggest a cautious outlook for investors.

Core Scientific insider sales trend: director Duchene sells shares below market while company’s AI expansion fuels a 27% monthly rally, showing gains‑harvesting but not downside risk.

Core Scientific insider selling: Todd Duchene’s April 16 sale, 16,741 shares at $19.08, reflects routine portfolio rebalancing amid the company’s shift to high‑performance computing.

Core Scientific insider sales: Todd M. Duchene sells 10,000+ shares under a Rule 10b‑5‑1 plan—structured, not panic. Understand the impact on CS stock and why it doesn’t signal trouble.

Core Scientific’s CEO unlocks a performance‑based PSU, buying 741k shares to signal confidence, while insider activity and 52‑week highs suggest a cautiously optimistic outlook.

Core Scientific CFO’s rapid insider sales raise red‑flag signals: 98,671 shares sold amid falling stock, hinting at possible valuation shifts.